000780462 000__ 05733cam\a2200493Ii\4500
000780462 001__ 780462
000780462 005__ 20230306143011.0
000780462 006__ m\\\\\o\\d\\\\\\\\
000780462 007__ cr\nn\nnnunnun
000780462 008__ 170329s2017\\\\sz\a\\\\o\\\\\000\0\eng\d
000780462 019__ $$a980498842$$a980739601$$a980829154$$a981199430$$a981685741$$a981895700$$a984848548
000780462 020__ $$a9783319516738$$q(electronic book)
000780462 020__ $$a3319516736$$q(electronic book)
000780462 020__ $$z9783319516721
000780462 020__ $$z3319516728
000780462 0247_ $$a10.1007/978-3-319-51673-8$$2doi
000780462 035__ $$aSP(OCoLC)ocn979992136
000780462 035__ $$aSP(OCoLC)979992136$$z(OCoLC)980498842$$z(OCoLC)980739601$$z(OCoLC)980829154$$z(OCoLC)981199430$$z(OCoLC)981685741$$z(OCoLC)981895700$$z(OCoLC)984848548
000780462 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dEBLCP$$dGW5XE$$dYDX$$dN$T$$dOCLCQ$$dNJR$$dUAB$$dOCLCF$$dIOG$$dCOO$$dAZU$$dUPM$$dOCLCO
000780462 049__ $$aISEA
000780462 050_4 $$aRA401.A1
000780462 08204 $$a362.17/82$$223
000780462 24500 $$aPharmaceutical policy in countries with developing healthcare systems /$$cZaheer-Ud-Din Babar, editor.
000780462 264_1 $$aCham, Switzerland :$$bAdis,$$c2017.
000780462 300__ $$a1 online resource (xii, 430 pages) :$$billustrations.
000780462 336__ $$atext$$btxt$$2rdacontent
000780462 337__ $$acomputer$$bc$$2rdamedia
000780462 338__ $$aonline resource$$bcr$$2rdacarrier
000780462 347__ $$atext file$$bPDF$$2rda
000780462 5050_ $$aForeword; Preface; Contents; Chapter 1: Introduction; 1.1 Pharmaceutical Policy andßtheßRight toßHealth; 1.2 Pharmaceutical Production andßSupply; 1.3 Access toßAffordable Drugs; 1.4 Conclusion; References; Part I: Low and Lower Middle Income Countries; Chapter 2: Pharmaceutical Policy inßtheßEast African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania; 2.1 Background; 2.1.1 Focus ofßThis Chapter; 2.1.2 Health System ofßtheßEAC (Health System andßHealth Indicators); 2.2 Pharmaceutical Situation ofßtheßEAC; 2.3 EAC Medicines Policy, Legislative andßRegulatory Environment.
000780462 5058_ $$a2.4 Conclusions: Summary andßWay ForwardReferences; Chapter 3: Pharmaceutical Policy inßPakistan; 3.1 Pakistan; 3.1.1 Country Profile; 3.2 Health System ofßPakistan; 3.2.1 Health System; 3.2.2 Health Indicators; 3.3 Pharmaceutical Situation ofßtheßCountry; 3.3.1 Pharmaceutical Industry andßKey Statistics; 3.4 Country's Regulatory Environment; 3.4.1 Medicines Regulatory Authority; 3.4.2 Quality Control; 3.4.3 Pharmacovigilance; 3.4.4 Counterfeit Medicines; 3.5 Medicines Supply System; 3.5.1 Procurement; 3.5.2 Distribution; 3.6 Medicines Financing; 3.6.1 Medicines Expenditures inßGeneral.
000780462 5058_ $$a3.6.2 Medicines Pricing3.6.3 Affordability; 3.6.4 Generic Medicines; 3.7 Medicines Use (Issues Impacting onßRationale Medicines Use inßtheßCountry); 3.7.1 Medicines Use inßGeneral (in Community Pharmacies, Dispensing Doctors andßGeneral Hospital Sector); 3.7.2 Essential Medicine List, Selection ofßEssential Medicines andßStandard Treatment Guidelines; 3.7.3 Prescribing Behaviour inßGeneral (Factors Affecting Prescribing Behaviour); 3.7.4 Medicines' Promotional Practices; 3.7.5 The Role ofßPharmacist inßCommunity andßHospital Environments.
000780462 5058_ $$a3.7.6 Medicines Use Research (Including Drug Utilization Evaluation Research)3.8 Summary andßFuture Direction; References; Chapter 4: Pharmaceutical Policy inßtheßPhilippines; 4.1 The Philippines Health System; 4.1.1 Health System ofßPhilippines; 4.1.2 Health Indicators; 4.2 The Philippines Pharmaceutical Sector; 4.3 Pharmaceutical Regulation inßtheßPhilippines; 4.3.1 Quality Control; 4.3.2 Pharmacovigilance; 4.3.3 Substandard andßCounterfeit Medicines; 4.4 Medicines Supply System inßtheßPhilippines; 4.4.1 The Medicines Supply System; 4.5 Medicines Financing; 4.5.1 Medicine Pricing.
000780462 5058_ $$a4.5.2 Price Monitoring4.5.3 Medicines Access; 4.5.4 Medicines Access Programs ofßtheßDOH; 4.5.5 Industry Patient Assistance Programmes; 4.5.6 Generic Medicines; 4.6 Medicines Use; 4.6.1 Medicines Use inßGeneral; 4.6.2 Essential Medicines andßStandard Treatment Guidelines; 4.6.3 Pharmacoeconomics; 4.6.4 Prescribing Behaviour; 4.6.5 Medicines Promotional Practices; 4.6.6 Role ofßPharmacist; 4.6.7 Pharmaceutical Care Interventions andßAssessment ofßCommunity Pharmacy Practice; 4.6.8 Medicines Use Research; 4.7 Conclusions andßWay Forward; References; Chapter 5: Pharmaceutical Policy inßVietnam.
000780462 506__ $$aAccess limited to authorized users.
000780462 520__ $$aA comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.
000780462 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed April 12, 2017).
000780462 650_0 $$aPharmaceutical policy.
000780462 7001_ $$aBabar, Zaheer-ud-din,$$eeditor.
000780462 77608 $$iPrint version:$$tPharmaceutical policy in countries with developing healthcare systems.$$dCham, Switzerland : Adis, 2017$$z3319516728$$z9783319516721$$w(OCoLC)964645629
000780462 852__ $$bebk
000780462 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-51673-8$$zOnline Access$$91397441.1
000780462 909CO $$ooai:library.usi.edu:780462$$pGLOBAL_SET
000780462 980__ $$aEBOOK
000780462 980__ $$aBIB
000780462 982__ $$aEbook
000780462 983__ $$aOnline
000780462 994__ $$a92$$bISE